rhodamine 123 has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, A; Miyano, H; Saito, H; Watanabe, H | 1 |
| Kruglov, SS; Mechetner, EB; Rybalkina, EY; Stavrovskaya, AA; Stromskaya, TP; Turkina, AG; Zabotina, TN | 1 |
| Czyzewski, K; Styczynski, J | 1 |
3 other study(ies) available for rhodamine 123 and imatinib mesylate
| Article | Year |
|---|---|
Interaction of imatinib mesilate with human P-glycoprotein.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Cell Line; Drug Interactions; Fluoresceins; Fluorescent Dyes; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Rhodamine 123; Tumor Cells, Cultured | 2003 |
Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Evolution; Biological Transport; Fluorescent Dyes; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multidrug Resistance-Associated Proteins; Piperazines; Pyrimidines; Rhodamine 123 | 2008 |
Imatinib is a substrate for various multidrug resistance proteins.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Daunorubicin; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Multidrug Resistance-Associated Proteins; Piperazines; Pyrimidines; Rhodamine 123; Vault Ribonucleoprotein Particles | 2009 |